In the past few days, we’ve barely been able to keep up with the flood of articles about the progress with adult stem cells. The headlines read like medical miracles: “Doctors transplant windpipe with woman’s own stem cells“; “Bone marrow stem cells restore hearing, vision in animals“; “Researchers to use patient’s own stem cells to treat heart failure“; and “Mother-of-two becomes first transplant patient to receive a whole organ transplant grown from her own stem cells.” And those were all articles published just THIS week!
As the Family Research Council reports:
The amazing flexibility of adult stem cells and induced pluripotent stem cells (iPS) has launched the scientific community into a new era of almost daily discoveries.
Although ethical alternatives are light years ahead of the research that destroys innocent human life, the incoming Obama administration insists on revisiting a failed and controversial technique — embryonic stem cell (ESC) research.
While iPS is already treating patients, the over-hyped and underperforming ESC will have a new champion in Obama’s health care expert, R. Alta Charo, a staunchly abortion, cloning, and embryo research advocate.
A professor and advisor to Planned Parenthood’s Guttmacher Institute, Charo was appointed to the Obama transition team last week.
Obviously, a policy change on stem cells is coming — one that is unlikely to favor principle, progress, or patients.